Brief: TherapeuticsMD Announces First Quarter 2022 Financial Results
16/05/2022 21:08
May 16 (Reuters) - TherapeuticsMD Inc TXMD.O :
* THERAPEUTICSMD ANNOUNCES FIRST QUARTER 2022 FINANCIAL
RESULTS
* THERAPEUTICSMD INC - QUARTERLY TOTAL NET PRODUCT REVENUE
OF
$19.3 MILLION
* THERAPEUTICSMD INC QTRLY LOSS PER COMMON SHARE, BASIC AND
DILUTED$5.69
Source text for Eikon: ID:nBw4PVRNva
Further company coverage: TXMD.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on TherapeuticsMD
See all newsBrief: TherapeuticsMD Announces First Quarter 2026 Financial Results
TherapeuticsMD swings to Q1 net income as license revenue rises
TherapeuticsMD swings to Q3 profit, license revenue climbs
Brief: TherapeuticsMD Q1 Operating Expenses USD 1.264 Million
Brief: Therapeuticsmd - Files Lawsuit Against Mayne Pharma For Breach Of Contract